Senores Pharmaceuticals Limited has informed the Exchange regarding Monitoring Agency Report for the quarter ended December 31, 2025.
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has submitted a Monitoring Agency Report for the quarter ended December 31, 2025 to the exchange. Monitoring Agency Reports are routine compliance filings typically submitted in connection with funds raised through instruments like QIPs, rights issues, or preferential allotments. The filing confirms adherence to the stated purpose of fund utilisation as per the placement document. No specific details on instrument type, pricing, or investor names are disclosed in this headline.
Routine compliance filing with limited direct impact on shareholders. Investors should watch for any observations or deviations noted in the actual report, which could signal changes in the use of proceeds.